Pulmonary Function in Diabetes

2010/03/26 by Bram van den Borst, Harry R. Gosker, Maurice P. Zeegers +1 · 25 citations
Medicine · #Chronic Obstructive Pulmonary Disease (COPD) Research #Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis #Pulmonary Hypertension Research and Treatments

paper · pdf · doi:10.1378/chest.09-2622

Citations

• Is the Lung a 'Target Organ' in Diabetes Mellitus?
• Pulmonary Function in Patients with Diabetes Mellitus

Cited by

• Metabolic syndrome biomarkers predict lung function impairment: a nested case-control study. [europepmc]
• The clinical potential of exhaled breath analysis for diabetes mellitus. [europepmc]
• Pulmonary function tests in type 2 diabetes mellitus and their association with glycemic control and duration of the disease. [europepmc]
• Non-traditional risk factors are important contributors to the racial disparity in diabetes risk: the atherosclerosis risk in communities study. [europepmc]
• Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease. [europepmc]
• The temporal relationship between poor lung function and the risk of diabetes. [europepmc]
• Significance of Exhaled Breath Test in Clinical Diagnosis: A Special Focus on the Detection of Diabetes Mellitus. [europepmc]
• Impaired lung function is associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in middle-aged and elderly Chinese. [europepmc]
• Type 2 diabetes is associated with an increased prevalence of respiratory symptoms as compared to the general population. [europepmc]
• Impact of diabetes mellitus on functional exercise capacity and pulmonary functions in patients with diabetes and healthy persons. [europepmc]
• Management of the COPD Patient with Comorbidities: An Experts Recommendation Document. [europepmc]
• Diabetes Mellitus Contributes to Idiopathic Pulmonary Fibrosis: A Review From Clinical Appearance to Possible Pathogenesis. [europepmc]
• Interstitial lung disease and diabetes. [europepmc]
• Non-linear association between diabetes mellitus and pulmonary function: a population-based study. [europepmc]
• Diabetic fibrosis. [europepmc]
• Pulmonary function tests in type 2 diabetes: a meta-analysis. [europepmc]
• Cystic fibrosis-related diabetes and lung disease: an update. [europepmc]
• Idiopathic pulmonary fibrosis and diabetes mellitus: a meta-analysis and systematic review. [europepmc]
• Association between Comorbidities and Preserved Ratio Impaired Spirometry: Using the Korean National Health and Nutrition Examination Survey IV-VI. [europepmc]
• Therapeutic approaches targeting molecular signaling pathways common to diabetes, lung diseases and cancer. [europepmc]
• Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease. [europepmc]
• Diabetic Pneumopathy-A New Diabetes-Associated Complication: Mechanisms, Consequences and Treatment Considerations. [europepmc]
• Preserved ratio impaired spirometry with or without restrictive spirometric abnormality. [europepmc]
• Diabetic microvascular disease in non-classical beds: the hidden impact beyond the retina, the kidney, and the peripheral nerves. [europepmc]
• Triglyceride-glucose index and obstructive sleep apnea: a systematic review and meta-analysis. [europepmc]